Corrigendum to "Rare variant of hypoxia-inducible factor-1α (HIF-1A) and breast cancer risk in Korean women" [Clinica Chimica Acta 389 (2008) 167-170] (DOI:10.1016/j.cca.2007.12.005);Rare variant of hypoxia-inducible factor-1α (HIF-1A) and breast cancer risk in Korean women

Clinica Chimica Acta

Volumn 389, Issue 1-2, 2008, Pages 167-170

  Lee, Ji Young ^a   Choi, Ji Yeob ^b   Lee, Kyoung Mu ^c   Park, Sue Kyung ^a   Han, So Hee ^a   Noh, Dong Young ^a   Ahn, Sei Hyun ^e   Kim, Dong Hyun ^d   Hong, Yun Chul ^a   Ha, Eunhee ^e   Yoo, Keun Young ^a,f   Ambrosone, Christine B ^b   Kang, Daehee ^a,g  

^a Seoul National University College of Medicine   (South Korea)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Hallym University College of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f National Cancer Center   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

Breast cancer; Clinicopathologic features; HIF 1A; Polymorphism

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; KOREA; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 38649102484     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.02.001     Document Type: Erratum

References (17)

1. Wang G.L., and Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270 (1995) 1230-1237
2. Lopez-Lazaro M. Hypoxia-inducible factor 1 as a possible target for cancer chemoprevention. Cancer Epidemiol Biomark Prev 15 (2006) 2332-2335
3. Tanimoto K., Yoshiga K., Eguchi H., et al. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24 (2003) 1779-1783
4. Zhong H., De Marzo A.M., Laughner E., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59 (1999) 5830-5835
5. Bos R., van Diest P.J., van der Groep P., Shvarts A., Greijer A.E., and van der Wall E. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6 (2004) R450-R459
6. Bos R., van der Groep P., Greijer A.E., et al. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97 (2003) 1573-81
7. Kimbro K.S., and Simons J.W. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr-Relat Cancer 13 (2006) 739-749
8. Fu X.S., Choi E., Bubley G.J., and Balk S.P. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63 (2005) 215-221
9. Ollerenshaw M., Page T., Hammonds J., and Demaine A. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 153 (2004) 122-126
10. Chau C.H., Permenter M.G., Steinberg S.M., et al. Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 4 (2005) 1222-1225
11. Han S.H., Lee K.M., Choi J.Y., et al. CASP8 polymorphisms, estrogen and progesterone receptor status and breast cancer risk. Breast Cancer Res Treat (2007; Oct 17) [Electronic publication ahead of print]
12. Dales J.P., Garcia S., Meunier-Carpentier S., et al. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer 116 (2005) 734-739
13. Mabjeesh N.J., and Amir S. Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol 22 (2007) 559-572
14. Bos R., Zhong H., Hanrahan C.F., et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93 (2001) 309-14
15. Quintero M., Mackenzie N., and Brennan P.A. Hypoxia-inducible factor 1 (HIF-1) in cancer. Eur J Surg Oncol 30 (2004) 465-468
16. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev 3 (2003) 721-732
17. Kuwai T., Kitadai Y., Tanaka S., et al. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep 12 (2004) 1033-1037